Thomas Skelton
Cardiovascular Disease · Jackson, MSNPI 1174054605
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 10.6% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for cardiovascular disease clinicians in MS, where the typical reported total is $3,650.
Across 78 payments — averaging $32.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$269
- Novo Nordisk$246
- Inspire Medical Systems, Inc.$220
- Boehringer Ingelheim$209
- Regeneron Healthcare Solutions, Inc.$185
- Philips North America LLC$179
- plus $1K from 14 others
What the payments were for
- Food & beverage$2,538100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 18 | $269 |
| Novo Nordisk | 4 | $246 |
| Inspire Medical Systems, Inc. | 5 | $220 |
| Boehringer Ingelheim | 9 | $209 |
| Regeneron Healthcare Solutions, Inc. | 5 | $185 |
| Philips North America LLC | 2 | $179 |
| Cvrx, Inc. | 1 | $146 |
| Novartis | 8 | $136 |
| E.r. Squibb & Sons, L.L.C. | 8 | $126 |
| Heartflow, Inc. | 1 | $121 |
| Penumbra, Inc. | 1 | $120 |
| Boston Scientific | 1 | $112 |
| Abiomed | 1 | $111 |
| Idorsia Pharmaceuticals US Inc | 1 | $108 |
| AstraZeneca | 4 | $73 |
| Procyrion, Inc. | 2 | $58 |
| Merck | 3 | $48 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $35 |
| Bridgebio Pharma, Inc. | 1 | $22 |
| Tricoast Surgical Solutions LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Barostim Neo System$146
- Inspire$132
- (9124) LM Undivided$131
- FFRct$121
- Indigo System$120
- WATCHMAN Access System$112
- Impella$111
- Tryvio$108
How this compares
$2,538 in reported general payments places this provider in the 35th percentile of 144 cardiovascular disease providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 27 | $104 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Jackson
- Donny StokesJackson$207K
- James BenslerJackson$64K
- Michael HallJackson$54K
- Tahsin QarqishJackson$39K
- Christopher LatourJackson$33K
- Varun SardarJackson$31K
- Olurotimi BaderoJackson$20K
- Michael PaymentJackson$16K
- James HaysJackson$16K
- Douglas HarkinsJackson$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.